Đang chuẩn bị liên kết để tải về tài liệu:
Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The ABCSG-28 trial compared primary surgery followed by systemic therapy versus primary systemic therapy without surgery in patients with de novo stage IV BC. The present report describes QoL results of this trial. | Primary surgery versus no surgery in synchronous metastatic breast cancer patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

TÀI LIỆU LIÊN QUAN

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: An observational study

Male adolescents with contralateral blebs undergoing surgery for primary spontaneous pneumothorax may beneft from simultaneous contralateral blebectomies

Ebook Vitreoretinal disorders in primary care: Part 2

Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): Study protocol for a phase III randomized controlled trial

Ebook Vascular and endovascular surgery at a glance: Part 2

Reconstructive surgery in head and neck surgery: Part 2

CRITICS-II: A multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Endobronchial ultrasound in real life: Primary diagnosis and mediastinal staging of lung cancer in patients submitted to thoracic surgery

Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: A large population-based investigation

The CAIRO4 study: The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.